Taken together, these data suggest that while MCF7 breast cancer cells constitutively activate matriptase under normal conditions, the vast majority of the active matriptase is rapidly inhibited by HAI-1 though a small proportion of the active enzyme may be rapidly shed into the extracellular milieu. The gene discussed is SPINT1; the disease is breast carcinoma.